Jihwan Ha

Prof. Dr. Jihwan Ha

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Journal of Biomedical Informatics
Verified
Journal Article
Closed access
MCMinsoo Cho
Minsoo Cho
JHJihwan Ha
Jihwan Ha
CPChihyun Park
Chihyun Park
SPSanghyun Park
Sanghyun Park

1 February 2020 in Journal of Biomedical Informatics
Verified
Journal Article
Closed access
JHJihwan Ha
Jihwan Ha
CPChihyun Park
Chihyun Park
CPChanyoung Park
Chanyoung Park
SPSanghyun Park
Sanghyun Park

13 January 2023 in Knowledge-Based Systems
Verified
Journal Article
Closed access
JHJihwan Ha
Jihwan Ha

Verified
Journal Article
Open access
PDF file
JHJihwan Ha
Jihwan Ha
MicroRNAs (miRNAs) have drawn enormous attention owing to their significant roles in various biological processes, as well as in the pathogenesis of human diseases. Therefore, predicting miRNA–disease associations is a pivotal task for the early diagnosis and better understanding of disease pathogenesis. To date, numerous computational frameworks have been proposed to identify potential miRNA–disease associations without escalating the costs and time required for clinical experiments. In this regard, I propose a novel computational framework (MDMF) for identifying potential miRNA–disease associations using matrix factorization with a disease similarity constraint. To evaluate the performance of MDMF, I calculated the area under the ROC curve (AUCs) in the framework of global and local leave-one-out cross-validation (LOOCV). In conclusion, MDMF achieved reliable AUC values of 0.9147 and 0.8905 for global and local LOOCV, respectively, which was a significant improvement upon the previous methods. Additionally, case studies were conducted on two major human cancers (breast cancer and lung cancer) to validate the effectiveness of MDMF. Comprehensive experimental results demonstrate that MDMF not only discovers miRNA–disease associations efficiently but also deciphers the underlying roles of miRNAs in the pathogenesis of diseases at a system level.

27 May 2021 in IEEE Access
Verified
Journal Article
Open access
JHJihwan Ha
Jihwan Ha
CPChihyun Park
Chihyun Park
The crucial roles played by microRNAs (miRNAs) in regulating various biological functions and in disease incidence have been reported continuously over the past decades. Therefore, the identification of novel disease-related miRNAs could help in understanding human disease etiology and pathogenesis further. Due to the involvement of high cost and more time in clinical experiments, development of accurate and feasible computational models is considered highly significant. Here, we aim to present a novel computational model of metric learning for predicting miRNA-disease associations (MLMD). MLMD aims at learning miRNA-disease metric to unravel not only novel disease-related miRNAs but also the miRNA-miRNA and disease-disease similarities. Comprehensive experimental results clearly proved the outstanding performance of MLMD compared to several state-of-the-art methods. MLMD achieved a reliable AUC score of 0.9106 and 0.8786 in the framework of global and local leave-one-out cross validations (LOOCV), respectively. Furthermore, we implemented case studies on two major human cancers (breast cancer and lung cancer) for comparative analysis with already known disease-related miRNAs. Results revealed the top 50 potential candidates were all disease-related miRNAs based on human public databases and literature analysis. We conclude that MLMD could not only serve as practical and feasible framework for inferring potential miRNA-disease associations, but also provide clues for understanding the human complex diseases.

3 April 2020 in Cells
Verified
Journal Article
Open access
PDF file
JHJihwan Ha
Jihwan Ha
CPChihyun Park
Chihyun Park
CPChanyoung Park
Chanyoung Park
SPSanghyun Park
Sanghyun Park
The identification of potential microRNA (miRNA)-disease associations enables the elucidation of the pathogenesis of complex human diseases owing to the crucial role of miRNAs in various biologic processes and it yields insights into novel prognostic markers. In the consideration of the time and costs involved in wet experiments, computational models for finding novel miRNA-disease associations would be a great alternative. However, computational models, to date, are biased towards known miRNA-disease associations; this is not suitable for rare miRNAs (i.e., miRNAs with a few known disease associations) and uncommon diseases (i.e., diseases with a few known miRNA associations). This leads to poor prediction accuracies. The most straightforward way of improving the performance is by increasing the number of known miRNA-disease associations. However, due to lack of information, increasing attention has been paid to developing computational models that can handle insufficient data via a technical approach. In this paper, we present a general framework—improved prediction of miRNA-disease associations (IMDN)—based on matrix completion with network regularization to discover potential disease-related miRNAs. The success of adopting matrix factorization is demonstrated by its excellent performance in recommender systems. This approach considers a miRNA network as additional implicit feedback and makes predictions for disease associations relevant to a given miRNA based on its direct neighbors. Our experimental results demonstrate that IMDN achieved excellent performance with reliable area under the receiver operating characteristic (ROC) area under the curve (AUC) values of 0.9162 and 0.8965 in the frameworks of global and local leave-one-out cross-validations (LOOCV), respectively. Further, case studies demonstrated that our method can not only validate true miRNA-disease associations but also suggest novel disease-related miRNA candidates.